New scan could reveal hidden oxygen levels in pancreatic cancer
NCT ID NCT04395469
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a special PET-MRI scan using a tracer called FAZA can safely measure oxygen levels (hypoxia) in pancreatic tumors. About 20 adults with advanced, non-spreading pancreatic cancer will get two scans—before and after standard radiation. The goal is to see if this imaging method can help doctors understand how tumors respond to treatment, not to treat the cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Four-Drug cocktail aims to shrink pancreatic tumors before surgery
- Immune cells armed with antibody take on pancreatic cancer
- Radioactive injection takes on tough pancreatic cancer in early trial
- New drug AB801 aims to boost chemo and immunotherapy in tough cancers
- New PET tracer could light up pancreatic tumors
- Nutrition check may boost quality of life in pancreatic cancer